Back to Rankings

RXRX

RecursionF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
RXRX vs peer average
20/100
RXRX vs. peer average (F vs. C)
Grade spread
B 2 · C 3 · D 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

HROW is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $1.63B

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerHROWHarrow
RXRX
Recursion
HROW
Harrow
Grade
F
B
Momentum
22
75
Value
41
57
Sentiment
-
43
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs HROW

RXRX / HROW
Grade Position
Below peers
RXRX vs. peer average (F vs. C)
20/100
Momentum
22
HROW
Value
41
HROW
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RXRX
1
HROW
Harrow Inc Common
B
80/100
-3
2
CMPS
COMPASS Pathways Plc ADR
D
40/100
-1
3
MAZE
Maze Therapeutics Inc Common
D
40/100
-1
4
MLTX
MoonLake Immunotherapeutics Class A Common
D
40/100
-1
5
NTLA
Intellia Therapeutics Inc Common
C
60/100
-2
HROW is the first peer returned for this comparison set.